SC
MDLN

Shay Capital’s Medline Inc MDLN Stock Holding History

Shay Capital’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
25,000
-90,000
-78% -$3.97M 0.09% 163
2025
Q4 		$4.83M Buy
+115,000
New +$4.86M 0.5% 53

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Shay Capital's MDLN Position: Q1 2026 in Review

Shay Capital reduced its Medline Inc (MDLN) stake by 78% in Q1 2026, selling an estimated $3.97M and leaving 25,000 shares worth $1.11M. The position accounts for 0.09% of the portfolio, ranked #163.

Shay Capital first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.83M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Shay Capital held 25,000 shares of Medline Inc worth $1.11M as of Q1 2026.
  • Shay Capital sold 90,000 Medline Inc shares in Q1 2026, an estimated $3.97M.
  • Medline Inc made up 0.09% of Shay Capital's portfolio in Q1 2026, its #163 holding.
  • Shay Capital first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • Shay Capital's Medline Inc position peaked at $4.83M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.